Rigel Pharmaceuticals (RIGL) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.11% |
| Dec 31, 2025 | -22.00% |
| Sep 30, 2025 | -13.50% |
| Jun 30, 2025 | -3.22% |
| Mar 31, 2025 | 4.28% |
| Dec 31, 2024 | 4.64% |
| Sep 30, 2024 | 10.68% |
| Jun 30, 2024 | 15.26% |
| Mar 31, 2024 | 17.28% |
| Dec 31, 2023 | 15.03% |
| Sep 30, 2023 | 11.62% |
| Jun 30, 2023 | 13.77% |
| Mar 31, 2023 | 9.06% |
| Dec 31, 2022 | 12.85% |
| Sep 30, 2022 | -3.70% |
| Jun 30, 2022 | -1.61% |
| Mar 31, 2022 | -1.84% |
| Dec 31, 2021 | -10.82% |
| Sep 30, 2021 | -10.92% |
| Jun 30, 2021 | -10.07% |
| Mar 31, 2021 | 17.61% |
| Dec 31, 2020 | 14.61% |
| Sep 30, 2020 | 11.53% |
| Jun 30, 2020 | 8.46% |
| Mar 31, 2020 | 9.86% |
| Dec 31, 2019 | 7.28% |
| Sep 30, 2019 | 7.38% |
| Jun 30, 2019 | 8.58% |
| Mar 31, 2019 | 8.12% |
| Dec 31, 2018 | 9.52% |
| Sep 30, 2018 | 12.92% |
| Jun 30, 2018 | 11.71% |
| Mar 31, 2018 | 19.12% |
| Dec 31, 2017 | 17.25% |
| Sep 30, 2017 | 18.02% |
| Jun 30, 2017 | 16.49% |
| Mar 31, 2017 | 15.16% |
| Dec 31, 2016 | 21.30% |
| Sep 30, 2016 | 20.33% |
| Jun 30, 2016 | 19.40% |
| Mar 31, 2016 | -32.16% |
| Dec 31, 2015 | 6.56% |
| Sep 30, 2015 | -43.53% |
| Jun 30, 2015 | -34.89% |